C
CMPS
COMPASS Pathways Plc American Depository Shares
$11.27
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of COMPASS Pathways Plc American Depository Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$3.47
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.46
Nov 2
Posts
No posts about CMPS yet.
About COMPASS Pathways Plc American Depository Shares
COMPASS Pathways is a UK-based drug developer working on a lab-made version of psilocybin, the active ingredient in "magic mushrooms," as a treatment for depression that hasn't responded to standard antidepressants. The company has no approved products and earns no product revenue yet; it survives on cash raised from investors while running clinical trials, and would only start making money if regulators approve its therapy and it gets adopted by hospitals and clinics. Its shares trade in the US as American Depositary Shares under the ticker CMPS.